Reports

• Part D Plans Generally Include Drugs Commonly Used by Dual-Eligible Enrollees: 2024

  

• THE NATIONAL INSTITUTES OF HEALTH HAS MADE PROGRESS BUT COULD FURTHER IMPROVE ITS CLOSEOUT PROCESS FOR GRANTS AND SIMILAR AWARDS

  

• MEDICARE ADVANTAGE COMPLIANCE AUDIT OF SPECIFIC DIAGNOSIS CODES THAT INDEPENDENT HEALTH ASSOCIATION, INC. (CONTRACT H3362) SUBMITTED TO CMS

  

• Many States Lack Information To Monitor Maltreatment in Residential Facilities for Children in Foster Care

  

• NORTH CAROLINA DID NOT REPORT AND RETURN ALL MEDICAID OVERPAYMENTS FOR THE STATE’S MEDICAID FRAUD CONTROL UNIT CASES

  

• NIH Did Not Close Contracts in Accordance With Federal Requirements, Resulting in the Increased Risk of Fraud, Waste, and Abuse

  

• The Food and Drug Administration’s Inspection and Recall Process Should Be Improved To Ensure the Safety of the Infant Formula Supply

  

• CMS Could Strengthen Program Safeguards To Prevent and Detect Improper Medicare Payments for Short Inpatient Stays

  

• Washington Medicaid Fraud Control Unit: 2023 Inspection

  

• Spring 2024 Semiannual Report to Congress

  

• Medicare Remains Vulnerable to Fraud, Waste, and Abuse Related to Off-the-Shelf Orthotic Braces, Which May Result in Improper Payments and Impact the Health of Enrollees

  

• Plans and Enrollment Often Fell Short for Underrepresented Groups in a Sample of NIH-Funded Clinical Trials

  

• Medicaid Managed Care: States Do Not Consistently Define or Validate Paid Amount Data for Drug Claims;

  

• Selected CDC Racial and Ethnic Approaches to Community Health Program Recipients Generally Complied With Federal Requirements But Did Not Meet All Targets and Charged Some Unallowable Costs

  

• California Improperly Claimed $52.7 Million in Federal Medicaid Reimbursement for Capitation Payments Made on Behalf of Noncitizens With Unsatisfactory Immigration Status

  

• Department of Health and Human Services Met Many Requirements, but It Did Not Fully Comply With the Payment Integrity Information Act of 2019 and Applicable Improper Payment Guidance for the Fiscal Year 2023

  

• Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Fourth Quarter of 2023 

  

• Colorado Did Not Report and Refund the Correct Federal Share of Medicaid-Related Overpayments for Some Cases Identified by the State’s Program Integrity Section 

  

• New York Medical College Claimed Unallowable Grant Costs and Did Not Meet Certain Financial Conflict of Interest Requirements 

  

• California Generally Completed Medicaid Eligibility Actions During the Unwinding Period in Accordance With Federal and State Requirements